Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
09/17JOHNSON & JOHNSON : NY Files Charges Against J&J Over Opioids -- Update
DJ
09/17JOHNSON & JOHNSON : NY Files Charges Against J&J Over Opioids
DJ
09/17MERCK : Vaccinex Shares Climb 18% on Keytruda Collaboration With Merck
DJ
09/17Bristol Myers, Dr. Reddy's Settle Revlimid U.S. Patent Litigation
DJ
09/17U.S. plans for hundreds of millions of cheap, fast COVID-19 tests
RE
09/17ELI LILLY AND : Lilly, Amgen to Collaborate on Making Lilly's Potential Covid-19 Antibody Therapies
DJ
09/17TOP GLOVE BHD : looks to list in Hong Kong after 'supernormal' pandemic demand
RE
09/17Alibaba Health, Sinovac partner on virus inoculation platform
RE
09/17FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Buy rating from JP Morgan
MD
09/17MERCK KGAA : JP Morgan gives a Neutral rating
MD
09/17BioNTech CEO expects vaccine can be fridge-stored for two weeks
RE
09/17Takeda-led COVID-19 plasma product to begin trial this month
RE
09/17MERCK KGAA : Credit Suisse gives a Buy rating
MD
09/16SINOVAC BIOTECH : China's Sinovac to test coronavirus vaccine candidate in teenagers, children
RE
09/16ASTRAZENECA : Italy could have AstraZeneca COVID-19 shots by end November, IRBM biotech says
RE
Discover
09/16ASTRAZENECA : trial illnesses may not be due to COVID-19 shot - Oxford University
RE
09/16MERCK KGAA : Bernstein remains Neutral
MD
09/16NOVARTIS : ties bond sale to malaria treatment access in sustainability push
RE
09/16MERCK : says it has overcome production shortages in vaccine materials
RE
09/16ASTRAZENECA : trial illnesses may not be due to COVID-19 shot - Oxford Univ
RE
09/16Illumina in talks to buy cancer testing startup Grail - Bloomberg News
RE
09/16PHILIPS NV : Goldman Sachs gives a Buy rating
MD
09/16GERRESHEIMER AG : Goldman Sachs maintains a Buy rating
MD
09/16ELI LILLY AND : Covid-19 Antibody Drug Shown to Reduce Hospitalizations, Eli Lilly Says
DJ
09/16ASTRAZENECA : Serum Institute gets approval to resume India trial of AstraZeneca COVID vaccine
RE
09/16MERCK KGAA : JP Morgan sticks Neutral
MD
09/16MERCK KGAA : Goldman Sachs reiterates its Sell rating
MD
09/16TAKEDA PHARMACEUTICAL : Japan's Takeda to sell TachoSil surgical patch to Corza Health for 350 million euros
RE
09/16MERCK : Confirms 2020 Outlook; Prioritizes Lower Debt
DJ
09/16MERCK : Germany's Merck says it will focus on smaller takeovers
RE
09/16CSL : Philippines says engaging Western pharma firms, despite Duterte anger
RE
09/15ASTRAZENECA : U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate
RE
09/15ASTRAZENECA : U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry
RE
09/15ASTRAZENECA : U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry
RE
09/15ASTRAZENECA : U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate
RE
09/15ASTRAZENECA : Pfizer says coronavirus vaccine study shows mostly mild-to-moderate side effects
RE
09/15BAYER : settles thousands of U.S. Roundup cases with trial attorneys
RE
09/15REGENERON PHARMACEUTICALS : Roche exec says COVID-hit health systems at 'more or less' normal capacity
RE
09/15Bayer settles thousands of U.S. Roundup cases with trial attorneys
RE
09/15SOME VOLUNTEERS QUIT J&J COVID-19 TRIAL IN SPAIN AFTER ASTRAZENECA SCARE : investigator
RE
09/15Germany grants BioNTech, CureVac $745 million to speed up COVID-19 vaccine work
RE
09/15Tech, healthcare mega deals boost virus-stricken M&A market
RE
09/15GILEAD SCIENCES : Magrolimab Gets FDA Breakthrough Therapy Designation in Myelodysplastic Syndrome
DJ
09/15ELI LILLY AND : Lilly, Boehringer Ingelheim Get FDA Fast-Track Designation for Jardiance After Heart Attack
DJ
09/15THERMO FISHER SCIENTIFIC : Expands Lab Plastics Production for Covid-19 Supplies
DJ
09/15BAYER : Signs $25 Million License Agreement With US Company to Develop Breast Cancer Drug
DJ
09/15BioNTech wins $445 million German grant for COVID-19 vaccine
RE
09/15ASTRAZENECA : WHO praises AstraZeneca COVID-19 vaccine trial pause
RE
09/15ROCHE HOLDINGS AG : Goldman Sachs keeps its Buy rating
MD
09/15RELIEF THERAPEUTICS : sees top-line trial results for COVID-19 treatment in early Q4
RE
09/15MERCK : Makes $1 Billion Deal
DJ
09/15ROCHE HOLDINGS AG : Buy rating from JP Morgan
MD
09/15Tech leads crisis-driven M&A boom with $350 billion deal rush
RE
09/15MERCK KGAA : JP Morgan remains Neutral
MD
09/14South Korea to secure coronavirus vaccines for 60% of population
RE
09/14Asian stocks head higher on China data, markets eye Fed meeting
RE
09/14EXCLUSIVE : AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sources
RE
09/14Tencent, others to buy $516.12 million worth shares in China Evergrande New Energy Vehicle
RE
09/14ELI LILLY AND : U.S. Coronavirus Infections Fall From a Day Earlier -- 3rd Update
DJ
09/14MARINUS PHARMACEUTICALS : genetic epilepsy drug meets main goal of late-stage study
RE
09/14GILEAD SCIENCES : COVID SCIENCE-Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen
RE
09/14AstraZeneca COVID-19 vaccine trials resume in Brazil
RE
09/14Tech leads crisis-driven M&A boom with $350 billion deal rush
RE
09/14Eli Lilly's drug cuts COVID-19 recovery time in remdesivir-combo study
RE
09/14Gilead's shares rise after $21 billion deal for Immunomedics
RE
Discover
09/14ROCHE : exec criticises Trump drug price order, says 'exceeds authority'
RE
09/14Hospitalized Covid-19 Patients Recovered Faster With Arthritis Drug
DJ
09/14ROCHE : drugs chief criticises Trump drug price order, says 'exceeds authority'
RE
09/14Merck to buy $1 billion stake in Seattle Genetics, co-develop cancer therapy
RE
09/14NEUROCRINE BIOSCIENCES : launches Parkinson's therapy as COVID-19 related disruptions ease
RE
Prev.1   2  3  4  5  6  7  8  9  10Next